Skip to main content
logo
Carl Zeiss Meditec AG (ETR:AFX)
Germany flag Germany · Delayed Price · Currency is EUR
23.54
-0.04 (-0.17%)
At close: Mar 20, 2026

Revenue by Geography

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
EMEA Revenue
657.50M584.30M
EMEA Revenue Growth
12.53%12.95%
Americas Revenue
579.20M532.90M
Americas Revenue Growth
8.69%-6.62%
APAC Revenue
991.00M949.00M
APAC Revenue Growth
4.43%-5.21%
Revenue (Other)
-55.00K-73.00K
Revenue (Total)
2.23B2.07B
Revenue (Total) Growth
7.82%-1.11%

Revenue by Geography 2

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
Germany Revenue
1.29B1.23B
Germany Revenue Growth
4.92%-2.49%
North America Revenue
552.66M522.32M
North America Revenue Growth
5.81%-8.11%
Asia Revenue
86.07M83.33M
Asia Revenue Growth
3.29%-16.40%
Europe excl. Germany Revenue
294.18M226.47M
Europe excl. Germany Revenue Growth
29.90%45.43%
Revenue (Total)
2.23B2.07B
Revenue (Total) Growth
7.82%-1.11%

Revenue

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
Ophthalmology Revenue
1.72B1.59B
Ophthalmology Revenue Growth
8.47%0.80%
Microsurgery Revenue
503.94M476.96M
Microsurgery Revenue Growth
5.66%-6.99%
Revenue (Other)
--
Revenue (Total)
2.23B2.07B
Revenue (Total) Growth
7.82%-1.11%

Gross Profit

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
Ophthalmology Gross Profit
897.88M802.21M
Ophthalmology Gross Profit Growth
11.93%-9.53%
Microsurgery Gross Profit
277.32M286.42M
Microsurgery Gross Profit Growth
-3.18%-10.22%
Gross Profit (Total)
1.18B1.09B
Gross Profit (Total) Growth
7.95%-9.71%

EBITDA

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
Ophthalmology EBITA
187.19M153.28M
Ophthalmology EBITA Growth
22.13%-
Microsurgery EBITA
70.56M95.61M
Microsurgery EBITA Growth
-26.20%-
Operating Income (Total)
223.32M194.45M
Operating Income (Total) Growth
14.85%-44.14%

EBIT

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
Ophthalmology Earnings Before Interest and Taxes
154.32M100.43M
Ophthalmology Earnings Before Interest and Taxes Growth
53.66%-54.07%
Microsurgery Earnings Before Interest and Taxes
69.00M94.02M
Microsurgery Earnings Before Interest and Taxes Growth
-26.61%-27.39%
Operating Income (Other)
--
Operating Income (Total)
223.32M194.45M
Operating Income (Total) Growth
14.85%-44.14%

Key Performance Indicators

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13 Sep '12
Order Backlog
379.65M282.86M
Order Backlog Growth
34.22%-30.82%
Updated Sep 30, 2025. Data Source: Fiscal.ai.